The Peter Attia Drive

Quote · The Peter Attia Drive

#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

Explore episode Jun 8, 2026

Where this was said

How the brain produces and transports its own cholesterol using apoE lipoproteins

At 34:18 · chapter starts 29:00

Tom opens with the definitive statement: what is happening with brain cholesterol has zero connection to what is circulating in plasma. ApoB particles — the main cholesterol carriers in blood — cannot cross the blood-brain barrier. Instead, the fetal brain begins synthesizing its own cholesterol in the second and third trimesters, ramping up production because neurons and glial cells need massive amounts for their membranes and for myelin. Oligodendrocytes produce roughly 70% of brain cholesterol, primarily used to wrap axons and dendrites in the myelin sheaths that enable fast neural signaling. Microgliocytes serve as the brain's immune cells, and astrocytes handle much of the remaining synthesis. To move cholesterol between cells through the brain's interstitial space — the matrosome — the astrocytes package it into ApoE-containing lipoproteins that resemble plasma HDL in density but are fundamentally different in composition, carrying copies of ApoE rather than ApoA-1. These particles mature in the matrosome, and neurons take them up via LDL receptors and especially LRP1, both of which recognize ApoE. Tom argues the receptor should be renamed the ApoB/ApoE receptor to reflect its true ligand range across both body compartments.

Similar quotes